Clinical trial
Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence
NCT00142818 · Kyle Kampman, Other · Completed
Key facts
| NCT number | NCT00142818 |
|---|---|
| Title | Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence |
| Official title | A Phase II, Double-blind, Placebo-Controlled, Pilot Trial of the Combination of Modafinil and Naltrexone for the Treatment of Cocaine and Alcohol Dependence |
| Acronym | Mod-Nal |
| Lead sponsor | Kyle Kampman, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alcohol-Related Disorders, Alcoholism, Cocaine-Related Disorders |
| Intervention type | Drug |
| Interventions | Naltrexone, Modafinil, Placebo |
| Enrollment | 164 |
| Start date | Feb 1, 2006 |
| Primary completion | Aug 1, 2013 |
| Completion | Aug 1, 2013 |
| First posted | Sep 2, 2005 |
| Last update posted | Jul 16, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: